[New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials].

Autor: Kalashnikov VI; National Medical Research Center for Endocrinology., Michurova MS; National Medical Research Center for Endocrinology.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2022 Nov 22; Vol. 94 (10), pp. 1204-1210. Date of Electronic Publication: 2022 Nov 22.

[Atherosclerotic Cardiovascular Diseases and Type 2 Diabetes Mellitus - new Developments in the Treatment].

Autor: Kalashnikov VY; Endocrinology National Medical Research Center, Moscow., Michurova MS; Endocrinology National Medical Research Center, Moscow.

Publikováno v: Kardiologiia [Kardiologiia] 2021 Feb 10; Vol. 61 (1), pp. 78-86. Date of Electronic Publication: 2021 Feb 10.

Association of polymorphic markers of genes FTO , KCNJ11, CDKAL1, SLC30A8, and CDKN2B with type 2 diabetes mellitus in the Russian population.

Autor: Nikitin AG; Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency, Moscow, Russian Federation., Potapov VY; Clinic of New Medical Technologies 'Archimedes', Moscow, Russian Federation., Brovkina OI; Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency, Moscow, Russian Federation., Koksharova EO; Endocrinology Research Centre, Moscow, Russian Federation., Khodyrev DS; Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency, Moscow, Russian Federation., Philippov YI; Endocrinology Research Centre, Moscow, Russian Federation., Michurova MS; Endocrinology Research Centre, Moscow, Russian Federation., Shamkhalova MS; Endocrinology Research Centre, Moscow, Russian Federation., Vikulova OK; Endocrinology Research Centre, Moscow, Russian Federation.; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation., Smetanina SA; Tyumen State Medical University, Tyumen, Russian Federation., Suplotova LA; Tyumen State Medical University, Tyumen, Russian Federation., Kononenko IV; Endocrinology Research Centre, Moscow, Russian Federation.; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation., Kalashnikov VY; Endocrinology Research Centre, Moscow, Russian Federation., Smirnova OM; Endocrinology Research Centre, Moscow, Russian Federation.; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation., Mayorov AY; Endocrinology Research Centre, Moscow, Russian Federation.; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation., Nosikov VV; State Research Institute of Genetics and Selection of Industrial Microorganisms, Moscow, Russian Federation., Averyanov AV; Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency, Moscow, Russian Federation., Shestakova MV; Endocrinology Research Centre, Moscow, Russian Federation.; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Publikováno v: PeerJ [PeerJ] 2017 Jul 13; Vol. 5, pp. e3414. Date of Electronic Publication: 2017 Jul 13 (Print Publication: 2017).